Stem cell injection aims to prevent deadly liver complication
NCT ID NCT07276568
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase trial tests whether injecting special liver-like cells into the abdominal muscle can help prevent or treat Small-for-Size syndrome, a serious complication that can occur after partial liver surgery. The study involves 12 patients and focuses mainly on safety, checking for side effects and changes in liver function. If the approach proves safe, it may pave the way for larger studies to see if it truly improves outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Hepatocyte-like cells (derived from induced pluripotent stem cells)
What this could lead to
If successful, this could lead to a new way to prevent or treat Small-for-Size syndrome, a serious complication after liver surgery, potentially improving survival.
What could go wrong
This is a very early (Phase 1) trial with only 12 participants, so safety and effectiveness are not yet proven. There is a risk of injection-related side effects or the cells not working as hoped.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LIVER FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Friendship Hospital, Capital Medical University
Beijing, Province, 100050, China